Company fined over unapproved medicine ads

  • 📰 DailyExpress_MY
  • ⏱ Reading Time:
  • 13 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 83%

Belgique Nouvelles Nouvelles

Belgique Dernières Nouvelles,Belgique Actualités

Kota Kinabalu: A company was fined a total of RM7,500 for four counts of publishing advertisements not approved by the Medicine Advertisements Board.

On the first count, the company was fined RM1,500 by Sessions Court Judge Azreena Aziz, for publishing an advertisement of a medicine dated on Oct 16, 2022 in a newspaper without approval from the Medicine Advertisements Board. The charge stated that the advertisement had lead to the use of that description as a medicine, an appliance or a remedy for the purpose of prevention or treatment of the diseases and conditions of human beings.

* Follow us on Instagram and join our Telegram and/or WhatsApp channel for the latest news you don't want to miss. * Do you have access to the Daily Express e-paper and online exclusive news? Check out subscription plans available.

 

Merci pour votre commentaire. Votre commentaire sera publié après examen.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

 /  🏆 3. in BE

Belgique Dernières Nouvelles, Belgique Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Ipoh company director loses over RM300,000 in investment scamIPOH: A 58-year-old company director has lost over RM300,000 to scammers in an investment scheme he found on social media.
La source: staronline - 🏆 4. / 75 Lire la suite »

Company director loses nearly RM350,000 in non-existent investment scamIPOH: A company director lost RM348,673 after being deceived by a non-existent investment that used the ‘OSL’ application offered by his social media ...
La source: theSundaily - 🏆 25. / 51 Lire la suite »